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 24 
Abstract 25 
1. European rabbits (Oryctolagus cuniculus) have been exposed to rabbit haemorrhagic 26 
disease virus (RHDV) and myxoma virus (MYXV) in their native and invasive ranges for 27 
decades. Yet, the long-term effects of these viruses on rabbit population dynamics remain 28 
poorly understood.  29 
2. In this context, we analysed 17 years of detailed capture-mark-recapture data (2000 – 30 
2016) from Turretfield, South Australia, using a probabilistic state-space hierarchical 31 
modelling framework to estimate rabbit survival and epidemiological dynamics. 32 
3. While RHDV infection and disease-induced death were most prominent during annual 33 
epidemics in winter and spring, we found evidence for continuous infection of susceptible 34 
individuals with RHDV throughout the year. RHDV-susceptible rabbits had, on average, 35 
25% lower monthly survival rates compared to immune individuals, while the average 36 
monthly force of infection in winter and spring was ~ 38%. These combined to result in an 37 
average infection-induced mortality rate of 69% in winter and spring.  38 
4. Individuals susceptible to MYXV and immune to RHDV had similar survival probabilities 39 
to those having survived infections from both viruses, whereas individuals susceptible to both 40 
RHDV and MYXV had higher survival probabilities than those susceptible to RHDV and 41 
immune to MYXV. This suggests that MYXV may reduce the future survival rates of 42 
individuals that endure initial MYXV infection.  43 
5. There was no evidence for long-term changes in disease-induced mortality and infection 44 
rates for either RHDV or MYXV. 45 
6. We conclude that continuous, year-round virus perpetuation (and perhaps heterogeneity in 46 
modes of transmission and infectious doses during and after epidemics) acts to reduce the 47 
efficiency of RHDV and MYXV as biocontrol agents of rabbits in their invasive range. 48 
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However, if virulence can be maintained as relatively constant through time, RHDV and 49 
MYXV will likely continue realising strong benefits as biocontrol agents. 50 
 51 
Key-words: biocontrol, disease transmission, epidemiological dynamics, host-pathogen 52 
interactions, invasive species management, myxoma virus, rabbit haemorrhagic disease virus 53 
(RHDV), virulence 54 
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Introduction 74 
Understanding temporal changes in infection rates and mortality is crucial for predicting the 75 
effects of infectious diseases on wildlife populations. This is because the effect of fatal 76 
diseases, at the population level, depends on the intricate interplay of disease-induced 77 
mortality, host reproductive behaviour, and individual heterogeneity in infection propensity 78 
and intensity (Frank 1996; Alizon et al. 2009; Wells et al. 2017).  79 
The virulence of a pathogen (infection-induced mortality rates of hosts) and infection 80 
rate (the propensity of individuals susceptible to a disease to become infected) can depend on 81 
the mode of spread and the dose in which pathogens are transmitted, as well as the 82 
resistance/immunity of host individuals, all of which can vary temporally. Therefore, it is 83 
crucial to quantify temporal as well as spatial variation in apparent virulence and infection 84 
rate if host-pathogen (co) eco-evolutionary processes are to be better understood (Woolhouse 85 
et al. 2002). For example, if pathogens do not constantly persist in host populations but are 86 
repeatedly introduced, variation in the resulting virulence of different pathogen strains can 87 
cause temporal changes in the impact of the disease on host populations (Manning et al. 88 
2008). If the pathogen transmission process involves heterogeneity in the dosage of 89 
exposure/inoculum, the epidemiological dynamics can change fundamentally because of 90 
dose-dependent variation in mortality rates or variation of within-host replication of the 91 
pathogen and subsequent differences of transmission dynamics (Regoes, Ebert & Bonhoeffer 92 
2002). 93 
Understanding the consequences of such epidemiological processes in wild animal 94 
populations is of crucial interest for informing strategic actions in disease control and host 95 
management. These include eliminating unwanted diseases and improving biocontrol agents 96 
(Dwyer, Levin & Buttel 1990; Duffy, Shackelton & Holmes 2008). 97 
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The European rabbit, Oryctolagus cuniculus, is a well-studied disease-burdened 98 
species. Its two major viral diseases in the wild are myxomatosis, caused by the myxoma 99 
virus (MYXV), and rabbit haemorrhagic disease (RHD), caused by the rabbit haemorrhagic 100 
disease virus (RHDV). These viruses are particularly well studied, partly because they have 101 
been used as biocontrol agents in Australia and New Zealand. While rabbits are a keystone 102 
species that is traditionally hunted in their native range (Delibes-Mateos, Ferreras & 103 
Villafuerte 2009), they cause severe damage to native biodiversity and agricultural resources 104 
in their exotic range (Cooke 2012). Extensive population declines of rabbits, following the 105 
initial releases of MYXV and RHDV in their exotic range, are well-documented (Dwyer, 106 
Levin & Buttel 1990; Mutze, Cooke & Alexander 1998; Kerr 2012); as are declines in their 107 
native range (Moreno et al. 2007). However, long-term trends in relative pathogen virulence 108 
and infection rates have never been quantified in wild rabbits, despite their obvious 109 
importance in managing populations.  110 
In Australia, MYXV caused high mortality in infected rabbits upon release in 1950 111 
but disease severity waned with time (Kerr 2012) and, initially, the virulence of the virus 112 
declined (Fenner, Day & Woodroofe 1956; Dwyer, Levin & Buttel 1990). Something similar 113 
applies to RHDV, where rabbits appear to be increasing in disease resistance with multiple 114 
genes associated with immune defence (Schwensow et al. 2017a; Schwensow et al. 2017b), 115 
while laboratory experiments indicate that RHDV strains collected a decade after initial virus 116 
release in 1995 appear more virulent than the original strain in resistant wild rabbits 117 
(Elsworth et al. 2014).  RHDV can be transmitted through direct contact with infected 118 
individuals which are shedding viral particles in their secretions and excretions, or indirectly 119 
by means of fomites-contaminated food, bedding or water (Abrantes et al. 2012). 120 
Furthermore, RHDV can be transmitted by widely-dispersing insect vectors (e.g. blowflies), 121 
which can transmit the virus from rabbit carcases across wide distances to other geographic 122 
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regions (Kovaliski 1998; Schwensow et al. 2014). By comparison, MYXV strains of 123 
moderate virulence rely upon infected rabbits retaining virus-laden skin lesions for sufficient 124 
time to enable transmission across shorter distances by mosquitoes or fleas. MYXV is a large 125 
DNA virus able to ameliorate the rabbit’s immune responses and prolong infection. In 126 
contrast, RHDV replicates quickly, often killing the host before an effective anti-viral 127 
response can be initiated. 128 
Both RHDV and MYXV cause lifelong immunity for rabbits that survive infection 129 
and, in addition, RHDV maternal antibodies passed to kittens (young, immature rabbits) can 130 
prevent fatal disease in these individuals during infection. Therefore, these individuals are not 131 
at risk of dying from RHD before they have lost their natural resilience and/or maternal 132 
antibody protection against RHDV (McPhee et al. 2009; Matthaei et al. 2014). Consequently, 133 
the timing of seasonally driven birth-pulses in rabbits can affect the pool of susceptible host 134 
individuals, leading to temporal variation in disease (Mutze et al. 2014; Wells et al. 2015). 135 
The impact of such demographic fluctuations on disease epidemiology is of particular 136 
importance in rabbits, because they exhibit high fecundity along with pronounced changes in 137 
population size under changing environmental conditions (Rödel et al. 2004; Wells et al. 138 
2016b).  139 
Recent computational and methodological innovations are improving knowledge of 140 
disease dynamics through the development of advanced statistical and mechanistic models  141 
(Metcalf & Lessler 2017). This includes the development and application of Bayesian state-142 
space models of capture-mark-recapture data to disease burdened populations (Schofield & 143 
Barker 2011; Wells et al. 2017), allowing individual heterogeneity in disease status to be 144 
directly fitted to data (King 2012). Alternatively, disease impacts on survival parameters can 145 
be modelled by the delineation of ‘disease states’, using a ‘multistate’ capture-mark-recapture 146 
model (Lebreton & Pradel 2002). This is done by discretizing time-varying continuous 147 
7 
 
individual covariates, such as disease status, into a finite number of states. Doing so, avoids 148 
needing to model disease status as a time-varying continuous individual covariate, whose 149 
value must be known for all individuals on all occasions (Jones et al. 2015). 150 
In this analysis, we examined the impact of RHDV and MYXV on infection and 151 
survival rates of European rabbits, Oryctolagus cuniculus, using 17 years of detailed capture-152 
mark-recapture (CMR) surveys of rabbit population fluctuations and health status. We 153 
incorporated an ontogenetic growth model into a Bayesian state-space CMR model to 154 
estimate age-specific demographic processes and rates of infection. To account for 155 
uncertainty arising from incomplete details on when individuals became infected or died 156 
from the diseases (or other causes) we modelled a latent Markov process of infection 157 
dynamics (Schofield & Barker 2011) (Fig. 1).  158 
 159 
Materials and Methods 160 
2.1 Study area and rabbit monitoring  161 
Rabbits have been live-trapped at Turretfield Agricultural Research Centre (34°33′S, 162 
138°50′E, South Australia) at 8-12 week intervals, continuously since 1996 (Peacock & 163 
Sinclair 2009; Fordham et al. 2012; Mutze et al. 2014). The study area has a Mediterranean 164 
climate with cool, moist winters and hot, dry summers. The rabbit population is relatively 165 
closed, with neighbouring populations more than 2 km away.  166 
All live captures were uniquely marked with serially numbered ear tags (Leader 167 
Products Pty Ltd., Craigieburn, Australia), weighed to the nearest 10 g with Salter spring 168 
balances and sexed. Blood was collected from an ear vein for serological tests of RHDV and 169 
MYXV antibodies. Additionally, the study area and warrens were regularly surveyed for 170 
dead rabbits at intervals ≤ four weeks, increasing to weekly searches during spring (Sept-171 
Nov) when epizootics were most likely to occur, and at 1-7 day intervals following any 172 
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evidence of disease-related mortality. Each carcass was spot-sprayed with permanent non-173 
toxic dye to avoid repeated sampling and was returned to its original location to minimize 174 
bias on the natural spread of diseases. Ear tags on fresh carcasses gave evidence of the age of 175 
some of the dead individuals, and time since death was estimated according to the onset of 176 
rigor mortis, size of fly maggots or the state of decay.  177 
We analysed CMR and serology data from between January 2000 and August 2016, 178 
using a subset of 2,200 individuals with unequivocal serology data for all capture events. 179 
Each capture session (n = 83) was assigned to one of the following (southern hemispheric) 180 
seasons according to local climate: (i) Autumn: Mar – May, (ii) Winter: Jun – Aug, (iii) 181 
Spring: Sept-Nov, (iv) Summer: Dec-Feb. The date of the capture session was calculated as 182 
the median date of all captures made during a capture session.  183 
 184 
2.2 Disease state classification by immunological assays 185 
To detect RHDV antibodies, competition ELISA (cELISA), and ELISA tests for detecting 186 
IgA, IgG, IgM isotypes were used (Capucci, Nardin & Lavazza 1997; Cooke et al. 2000). We 187 
used threshold levels (Appendix 1) to classify RHD disease states as (i) seronegative 188 
(“susceptible”) (ii) seropositive kittens with maternal antibodies (“protected young”) and (iii) 189 
seropositive due to previous infection (“immune”). Possible serological cross-reaction with 190 
benign calicivirus (RCV-A1) was taken into account when interpreting ELISA results from 191 
the combination of tests outcomes (Liu et al. 2012). Antibodies against MYXV were detected 192 
using a specific ELISA (Kerr 1997), classifying rabbits as (i) seronegative with no detectable 193 
antibodies and therefore susceptible to infection/disease (“susceptible”) or (ii) seropositive 194 
with antibodies against disease. For MYXV, seropositive classifications may involve 195 
maternal antibodies in young rabbits or those produced after infection such that only old 196 
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individuals can be classified as “immune” (see below for the analytical approach to account 197 
for this uncertainty). 198 
 199 
2.3 Bayesian multistate capture-mark-recapture model 200 
To estimate the effects of diseases on rabbit survival and epidemiological parameters, we 201 
used a hierarchical state-space modelling framework to account for partially observed birth-202 
death and disease state transitions processes (Fig. 1). A full model description, code and 203 
model graph (Fig. S1) can be found in the Supporting Information. In brief, we modelled a 204 
(partially known) state variable z(i,t) to establish whether an individual is alive at time step t 205 
according to individual encounter histories (i.e. presence-absence data) and the underlying 206 
capture probability, which we allowed to vary among capture sessions. The survival 207 
probability Φ(i,t) estimates if individuals were alive conditional on whether they have been 208 
alive at a the previous time step. We used a scaling factor to account for unequal time 209 
intervals between capture sessions (average length of time intervals = 74 days, 1 SD = 27 210 
days). We used individual measures of body mass b(i,t) for estimating individual age and 211 
birth dates using the West-Brown-Enquist ontogenetic model and we projected all data on a 212 
continuous time scale (the first day of the study set to one) to express individual age and 213 
ontogenetic growth as Euclidean temporal distances (Wells et al. 2016a).  214 
We modelled Φ(i,t) based on logit-link functions as  215 
 logit(Φ(i,t)) = μΦ [agecat(i,t), year(t)] + βsex[sex(i)]+ βDZ[ηDZ(i,t), t]  (eqn 1).  216 
Here, μΦ is the intercept, which we allowed to vary among different age classes and over 217 
years. We considered individual age as a categorical variable agecat(i,t) with six unequal 218 
levels: 1) 1 – 180 days; 2) 181 – 365 days; 3) 1 – 3 years; 4) 3 – 6 years; 4) > 6 years. The 219 
coefficient βsex allows for variation in survival probability due to rabbit gender. The 220 
coefficient βDZ captures variation in survival of individuals in different disease states based 221 
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on five different categories of the auxiliary parameter ηDZ, which summarizes serostatus for 222 
both RHDV (state variable ηRHD as specified below) and MYXV (ηMYXV), respectively. 223 
Specifically, the categories for ηDZ were 1) all individuals < 90 days old, including ηRHD = 224 
‘maternal antibodies’ AND/OR ηMYXV = ‘antibodies against MYXV, 2) ηRHD = ‘susceptible’ 225 
AND ηMYXV = ‘susceptible’ (individuals ≥ 90 days old), 3) ηRHD = ‘susceptible’ AND ηMYXV = 226 
‘immune’ (individuals ≥ 90 days old), 4) ηRHD = ‘immune’ AND ηMYXV = ‘susceptible’ 227 
(individuals ≥ 90 days old), and 5) ηRHD = ‘immune’ AND ηMYXV = ‘immune’ (individuals ≥ 228 
90 days old). We used these categories to be able to make inference on the relative survival 229 
and infection rates for only those disease states for which direct comparison can be made, 230 
such as those only susceptible to a single virus and immune to the other versus those immune 231 
to both viruses. 232 
 233 
Disease status in state-space: We estimated unknown disease states RHD and MYXV for time 234 
steps where individuals were not captured based on their previous disease state. We assumed 235 
that only young rabbits < 90 days old can have effective maternal antibodies to RHDV or 236 
MYXV (Robinson et al. 2002). The transition probabilities between the different disease 237 
states can be summarized into C × C matrices (C = 3 according to three different disease 238 
states; probabilities in these matrices may vary according to individual age) with row sums of 239 
one. We accounted for a directional transition (governed by an underlying Markov process) 240 
between disease states, i.e. the probability to be in any disease state is conditional on the 241 
previous state, meaning that once a rabbit is infected/immune they cannot become 242 
seronegative again. We modelled disease states for each individual and time step based on the 243 
matrix of transition probabilities using the sum to unity constraint of the multinomial 244 
distribution (once conditioned on age and previous disease state, each individual set of 245 
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transition probabilities Ψ is a vector of length C, depicting the probabilities of different 246 
disease states). In the case of RHD, the equation was: 247 
ηRHD(i,t) ~ Multinomial[Ψ*RHD[ηRHD(i,t-1), age(i,t) t] (C)]   (eqn 2). 248 
We used indicator variables to distinguish transition probabilities ΨRHD when individuals are 249 
alive (z(i,t)=1) from those prior to individual birth (z(i,t)=0, Idied(i,t)=0) in order to constrain 250 
unborn individuals (Iborn(i,t)=0) to the immature state. In this case, the respective transition 251 
probabilities Ψ0RHD comprise a vector of length C with the first value set to 1 and all others to 252 
0. Additionally, the indicator variable I90(i,t) constrained younger individuals < 90 days to 253 
transition into any disease state given ΨjuvRHD (thus, Ψ*RHD corresponds to either ΨRHD, Ψ0RHD, 254 
or ΨjuvRHD according to individual age and may vary over time steps; see  model code in 255 
Appendix 1). Here, we used the Dirichlet distribution (with equal underlying alpha-values) 256 
as conjugate prior of the multinomial distribution. Older individuals could not have maternal 257 
antibodies (I90(i,t) = 1). The probability for different disease states ΨRHD was estimated from 258 
the transition probability to sero-convert λ(t) (e.g. the transition from sero-negative to sero-259 
positive), where the probability to remain sero-negative is 1 - λ(i,t). 260 
We modelled the sero-conversion rate λ(t) with a logit-link function as 261 
 logit[λ(t)] = μλ(t)     (eqn 3). 262 
We used a hierarchical hyperprior model for the time-varying intercept μλ(t) as detailed 263 
below. 264 
The rate at which susceptible individuals acquire RHDV or MYXV at each time t (i.e. 265 
force of infection FoI(t)) was calculated as the proportion of seronegative individuals at the 266 
previous time step t-1 that have either sero-converted to seropositive or have died. Since 267 
death may have been caused by multiple drivers, we calculated the proportion of dead 268 
individuals likely to have died from disease based on the estimated disease effects on survival 269 
(βDZ). We chose this approach to calculate FoI, because sero-conversion rates (t) consider 270 
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only sero-conversion of alive individuals, disregarding the individuals that have died in the 271 
respective time step. 272 
To test whether temporal fluctuation and correlations in FoI for the two viruses were 273 
driven by the serology data (i.e. observed individual sequences of sero-conversions) or 274 
mortality we run an additional model as described above that excluded the disease state effect 275 
βDZ from the model of Φ.  276 
 277 
Model fitting and diagnostics: The model was fitted in a Bayesian framework with Markov 278 
Chain Monte Carlo (MCMC) sampling, using the Gibbs Sampler in OpenBUGS 3.2.2 (Lunn 279 
et al. 2009). Chain mixing was inspected both visually and with the Gelman-Rubin diagnostic 280 
(most values < 1.2). We expressed all rates/probabilities as monthly (31-day-period) values. 281 
All parameter estimates from the state-space model are shown as posterior modes and 95% 282 
highest posterior density credible intervals (CI) from 5,000 MCMC samples (including 50% 283 
CI in plots). See Supporting Information for details on the model fit and code. Data 284 
formatting and visualization were conducted in the R software for statistical and graphical 285 
computing Version 3.4 (R Development Core Team 2017). 286 
 287 
2.4 Virulence estimation from capture-mark-recapture data 288 
The infection-induced mortality rate γ could not be directly estimated from the given data, as 289 
the interplay of virulence (γ) and force of infection rate (FoI) determines changes in 290 
population-level survival rates of susceptible versus immune rabbits (Hethcote 2000). 291 
However, assuming that susceptible rabbits that do not become infected have the same 292 
survival rate as immune individuals (i.e. no prolonged disease effect), and if FoI is the 293 
proportion of individuals to become infected, infection-induced mortality rate can be 294 
approximated as follows: 295 
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 γ = 1 – (ΦS – (1 - FoI)) / FoI    (eqn 4) 296 
with S being the average survival rate of the pool of all susceptible rabbits and the survival 297 
rate for immune rabbits set to I = 1. Note that this approach only gives reliable output if S 298 
> FoI, because only then would the proportion of susceptible rabbits not to become infected 299 
have equal survival probabilities as immune rabbits.  300 
 301 
Results 302 
The disease dynamics induced by rabbit haemorrhagic disease virus (RHDV) and myxoma 303 
virus (MYXV) showed different patterns of short and long-term effects of infection on 304 
population-level survival rates (Figs. 2, Fig. S2).   305 
Rabbits fully susceptible to RHDV (and immune to MYXV) had significantly lower 306 
survival rates (estimated at the population level) than immune adults throughout the year, 307 
with monthly survival rates being on average 25% less than for susceptible rabbits (odds ratio 308 
of hyperprior-level estimate 0.75, CI 0.68 – 0. 82) (Fig. 2). There was no evidence for any 309 
long-term temporal trend in changes in the survival rates of RHDV susceptible versus 310 
immune adults (Fig. S2). We did not identify any clear seasonal differences in the relative 311 
survival rates of RHDV susceptible versus immune adults (Fig. S2) despite a variable force 312 
of infection (FoI, estimated across all age classes) as detailed below.  313 
In contrast, survival rates of rabbits susceptible to MYXV (and immune to RHDV) 314 
were slightly higher than those of immune adults at the population-level (all odds ratios for 315 
seasonal hyperprior-level estimates 1.18 – 1.22, CIs ranging between 1.04 – 1.35) (Fig. 2). 316 
As with RHDV, there was no apparent long-term temporal trend in estimated survival rates of 317 
MYXV susceptible and immune adults (Fig. S2). The absence of very different survival rates 318 
for individuals susceptible to MYXV versus individuals immune to MYXV was not caused 319 
by the absence of infection since FoI estimates were well above zero during the study period 320 
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(Fig. 3). Therefore, in most capture sessions, subsets of the pool of susceptible individuals 321 
were infected. Individuals susceptible to both RHDV and MYXV had significantly higher 322 
survival rates than immune rabbits in all seasons (all odd ratio 1.13 – 1.67 with CIs between 323 
1.02 – 1.99) (Fig. 2, Fig. S3). Crucially, we found relatively higher survival rates of 324 
individuals susceptible to both viruses compared to those susceptible to RHDV and immune 325 
to MYXV throughout the year (Fig. 2), indicating that rabbits immune to MYXV have a 326 
lower survival rate than susceptible individuals. Young rabbits, including those with maternal 327 
antibodies to either virus, had significantly lower survival rates than immune rabbits in spring 328 
(Fig. 2, Fig. S4), indicating that waning protection by antibodies result in infection and 329 
potentially, mortality, later in the same year. 330 
The estimated force of RHDV infection across capture sessions peaked annually in 331 
most years in winter and spring (Fig. 3). The force of RHDV infection was constantly < 53% 332 
in 2003 and 2004, indicating that at least in some years large proportions of susceptible 333 
individuals are likely to escape infection (see Fig. S5 and Fig. S6 for the proportion of 334 
estimated and observed individuals in different disease states, respectively). The FoI for 335 
RHDV dropped close to zero in only a few capture sessions, providing evidence for potential 336 
continuous infection of susceptible rabbits throughout most years (Fig. 3). However, there is 337 
a possibility that this could be because the use of hyperpriors in our modelling pulled 338 
unknown values to the ‘average’. Seasonal fluctuations in the FoI were less pronounced 339 
between 2011 – 2015 than in previous years.  340 
The average monthly infection-induced mortality rate for RHDV was ~ 69% 341 
according to an average monthly FoI in winter and spring of 38% (average of all winter and 342 
spring posterior mode estimates) and 25% lower average survival rates of RHDV-susceptible 343 
individuals (see Methods). Due to large uncertainty in all estimates, we were not able to 344 
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approximate changes in infection-induced mortality over time with a high level of 345 
confidence.  346 
The monthly force of MYXV infection peaked in spring/summer in various years, 347 
indicating some evidence of seasonality in infections (Fig. 3). The proportions of MYXV-348 
immune adults tended to peak every 2-4 years, which contrasts to the mainly annual 349 
oscillations found for RHDV antibody status (Fig. S5). 350 
Changes in the force of MYXV infection correlated strongly with the force of RHDV 351 
infection (Spearman’s r = 0.80, CI 0.70 – 0.88), suggesting some synchrony in infection rates 352 
with the two diseases. This observed synchrony is driven largely by the serology data and not 353 
only mortality events, as evident from a model without the disease state effect on survival 354 
(i.e. excluding βDZ from the model of Φ; see Fig. S7 and Fig. S8). 355 
Overall, monthly survival rates of those rabbits immune to both diseases were 92% 356 
(CI 90 – 93%; corresponding to annual survival rates of 28 – 43%). Survival rates did not 357 
differ between males and females (odds ratio male/female 0.97, CI: 0.85 – 1.14). Capture 358 
rates in most capture sessions were < 40% and varied over time (Fig. S9), likely explaining 359 
why uncertainty in the estimates of individual disease states and the time-specific disease 360 
effect on rabbit survival led to large credible intervals. 361 
 362 
Discussion 363 
The threat of diseases to wildlife populations, and the efficiency of pathogens as biocontrol 364 
agents, can only be evaluated with an adequate understanding of how different components 365 
of demography and epidemiology interact and, ultimately, how such interplay affects survival 366 
rates prior to and after contracting diseases (Di Giallonardo & Holmes 2015). Analysing the 367 
effects of rabbit haemorrhagic disease virus (RHDV) and myxoma virus (MYXV), using data 368 
from the longest running wild rabbit capture-mark-recapture (CMR) program, provided new 369 
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insights into the epidemiology of these diseases and their effects on the survival (at the 370 
population level) of rabbits. We show that despite a strongly seasonal force of infection (FoI) 371 
for RHDV and MYXV, it is likely that susceptible rabbits can be infected (at least at low 372 
levels) throughout the year, having implications for rabbit conservation and biocontrol. We 373 
also show that the negative effect of MYXV on susceptible rabbits is not as immediate as for 374 
RHDV, with the pool of rabbits still susceptible to MYXV having similar monthly survival 375 
rates to animals that have contracted myxomatosis (and may die sometime after 376 
seroconversion). The force of infection for RHDV and MYXV was weak in some years, 377 
suggesting that large numbers of susceptible individuals can occasionally escape infection 378 
(Wells et al. 2015). However, this occurred rarely, and is unlikely to be a major driver of 379 
rabbit disease dynamics.  380 
We did not find any evidence of long-term changes in disease induced mortality and 381 
infection rates. However, this is despite the viruses having devastating impacts on rabbit 382 
survival when the epidemics first occurred, likely because initial disease dynamics are often 383 
transient and differ from long-term outcomes (Hastings 2004). Relatively constant rates of 384 
RHDV and MYXV induced mortality and infection rates over time are likely to be the result 385 
of strongly coupled co-evolutionary changes in host resistance and tolerance and pathogen 386 
invasiveness, each working to keep the other at bay. It might be that virulence of both viruses 387 
in the study population is being maintained at an optimum (assuming that viruses track 388 
changes in host resistance as they are capable of fast selection and genetic changes due to fast 389 
replication), which is most efficient for viral spread. If so, this has important implications for 390 
the use of these viruses as biocontrol agents for rabbits in their invasive range because these 391 
feedback processes carry long-term benefits for invasive species management, by 392 
maintaining negligible losses of virus virulence.  393 
 394 
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4.1 Epidemiological dynamics revealed from the CMR analysis  395 
Our results suggest that heterogeneity in key factors such as mode and dose of virus 396 
transmission, and/or the infection process, may reduce the efficiency of RHDV as a 397 
biocontrol agent at the population level, independent of the virulence of the virus. This is 398 
because we found (i) that individuals can potentially become infected after annual epidemics; 399 
(ii) that the force of RHDV infection oscillates over the year, leading to variation in the 400 
chances individuals become infected; and (iii) the average infection-induced mortality rate 401 
(69%) at Turretfield is lower than rates reported when RHD first spread (up to 95%; Mutze, 402 
Cooke and Alexander (1998)). Taken together, our results suggest that prolonged exposure of 403 
rabbits to RHDV (extending beyond seasonal outbreaks) and factors that cause variation in 404 
infection-induced mortality (such as variation in rabbit resistance to infection and virulence 405 
of the virus - the latter resulting potentially from variable modes and doses of infection) are 406 
among the likely mechanisms explaining the observed lower than expected mortality rate for 407 
RHDV at the study site.  408 
We show that the two diseases have rather different effects on rabbit survival rates. 409 
The pool of individuals susceptible to RHDV had lower survival rates compared to those that 410 
had survived a previous infection (immune individuals). In contrast, we found that 411 
individuals susceptible to both viruses had almost always higher survival rates than 412 
individuals susceptible to RHDV but immune to MYXV. This indicates that individuals 413 
immune to MYXV have relatively lower survival rates than those susceptible to MYXV. 414 
Therefore, myxomatosis has a longer term effect on rabbit survival than RHDV for 415 
individuals that ‘run the gauntlet’ of perpetual disease burdens.  416 
Our finding that the pool of rabbits that have survived MYXV infection have lower 417 
survival rates than equivalent, unchallenged rabbits, is supported (albeit indirectly) by field 418 
research from other sites in Australia. For example, Parer, Conolly and Sobey (1985) found 419 
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that MYXV consistently kept rabbit abundance at low levels for several months after an 420 
epidemic; and rabbit survival in dry and food-scarce summer months tends to be lower after a 421 
MYXV epidemic earlier in the year. A possible explanation is that infection with MYXV in 422 
spring depletes the fat reserves of rabbits, leading to morbidity and mortality during summer 423 
months when food resources are scarce (Brian Cooke, personal correspondence).   424 
Alternative drivers that could cause lower survival rates for rabbits that have survived 425 
MYXV infection (compared to those susceptible to infection) include MYXV directly 426 
affecting the ability of rabbits to digest food, following the acute stages of the disease. This is 427 
because receptors involved in the immune response have been linked to digestive disorders in 428 
domestic rabbits (Rahman & McFadden 2011; Yang et al. 2013). Another possible 429 
explanation is that exposure to MYXV compromises the health of rabbits in such a way that 430 
it reduces the survival of individuals subsequently infected by RHDV. These suggestions are 431 
speculative, and not mutually exclusive, but could be a starting point for examining why 432 
rabbits challenged with MYXV have survival rates similar to susceptible animals. 433 
When interpreting these results, it is important to consider that the odds ratios of the 434 
survival of susceptible and immune rabbits (i.e. those surviving infection) do not provide 435 
precise estimates of infection-induced mortality rates. This is because only a fraction of 436 
individuals in the pool of susceptible rabbits may get infected at any one time step, due to the 437 
underlying force of infection and disease transmission rate (Hethcote 2000). Furthermore, it 438 
should be noted that (i) our inferences were drawn from data collected over average time 439 
intervals of 74 days, whereas viral spread can potentially occur over shorter time periods 440 
(Mutze et al. 2014); (ii) our analysis did not directly explore whether exposure to MYXV 441 
compromises the immunity of rabbits in such a way that it reduces survival to subsequent 442 
infection from RHDV. If there is a strong interaction between the two diseases, whereby 443 
RHDV is more likely to cause the death of MYXV-immune compared to MYXV-susceptible 444 
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individuals, then the reported time-delayed effects of MYXV could be being fostered (in full 445 
or part) by RHDV infection. Therefore, it is very possible that this new evidence of lower 446 
survival rates for rabbits that survived initial infection from MYXV (compared to susceptible 447 
rabbits) is the result of an interaction between MYXV and RHD on rabbit survival rates. 448 
In contrast to Mutze et al. (2014) we did not find evidence for any long-term temporal 449 
trend in changes in the survival rates of susceptible or protected young rabbits versus immune 450 
adults to RHDV. This is likely to reflect differences in the two approaches used to analyse the 451 
data. Where, in this instance, we were able to model directly the effect of disease status of 452 
individual rabbits on survival, using a larger number of individuals, without assuming 453 
discrete periods for RHD epizootics.    454 
 455 
4.2 Variable transmission modes and the efficiency of RHDV 456 
Our finding that RHDV can persist at low levels across the year is independently supported 457 
by relatively short-lived immunoglobulin M (IgM), being detected (at titres ≥ 40) in low 458 
numbers of rabbits throughout the year (Fig. S10). Since IgM is the first antibody to appear 459 
in response to initial exposure to RHDV (Lavazza & Capucci 2008) it confirms a likely 460 
annual persistence of RHDV at low levels in the rabbit population at Turretfield. Previously, 461 
it was observed that RHDV epidemics were generally initiated by variants of the virus, which 462 
were unlikely to have persisted and evolved in the local environment (Schwensow et al. 463 
2014). However, this pattern has changed in more recent years. Since 2010, single RHDV 464 
isolates collected at times following annual epidemics have shown variants most closely 465 
related to those from previous years (NS, unpublished results), suggesting that some RHDV 466 
variants perpetuate in the local environment. 467 
 If RHDV does indeed infect some susceptible individuals well after or before annual 468 
epidemics (i.e. during which time most carcasses with signs of disease-induced death are 469 
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found), what are the modes of disease transmission? The different modes of transmission 470 
could include (i) direct transmission from an infected alive rabbit, (ii) contact with a 471 
contaminated carcass in a burrow, and (iii) flies feeding on contaminated carcass and then 472 
defecating on burrow walls, pasture, or feeding around the eyes of rabbits. 473 
There is evidence that high abundances of arthropod vectors, such as flies 474 
(Calliphoridae and Muscidae), during epidemics, result in fly-borne virus transmission even 475 
over large geographic distances (Asgari et al. 1998), facilitating RHD epidemics through 476 
repeated virus introductions and enhanced spread. Furthermore, during and after epidemics, 477 
carcasses of RHDV-infected rabbits could potentially be a major source for viral spread, 478 
since infected carcasses have been found to contain viable viral particles for up to three 479 
months (Henning et al. 2005). Consequently, we hypothesize that infection from older 480 
carcasses could, at least in theory, provide lower doses of infectious particles for a short 481 
period of time, which cause lower infection-induced mortality rates outside epidemics. 482 
Alternatively, lower abundance of virus-carrying flies may result in lower abundance of virus 483 
particles in the environment, which, in turn, may lead to low dose contraction. Infection dose 484 
is likely to play an important role for the progression of RHDV. Experimental infections 485 
show that mortality rates are dose-dependent, with lower doses tending to result in fewer 486 
deaths (Nyström et al. 2011).  487 
If reasonably large proportions of susceptible individuals are only exposed to low 488 
dose infections, population-level infection-induced mortality will be much less than the 489 
mortality rate linked to high dose infections during epidemics. In this context, it would be 490 
interesting for future research to explore how temporal changes in the availability and decay 491 
rate of RHDV-infected carcasses, immediately following epidemics, impacts the rate and 492 
intensity (i.e. infection dosage) that susceptible rabbits become infected. If viruses are less 493 
likely to survive in carcasses that dry out more quickly (Henning et al. 2005) or decay more 494 
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rapidly, one would expect that changing environmental conditions would affect virus dose 495 
and the chance that susceptible rabbits become infected. These dynamics, could potentially 496 
explain the observed continuous force of infection in concert with lower average infection-497 
induced mortality rates compared to 20 years ago, i.e. when the first RHDV epidemics 498 
occurred in Australia.  499 
Therefore, it is likely that factors influencing RHDV transmission rather than 500 
virulence limit the number of rabbits killed by the disease. This argument could partly 501 
explain recent on-ground observations of increased survival (i.e. less infection-induced 502 
mortality) and abundance of South Australian rabbit populations (Mutze et al. 2015), and in 503 
silico evidence of rabbits escaping infection in some years (Wells et al. 2015).  504 
 505 
4.3 Future research into transmission pathways  506 
We believe that future research avenues should include investigating disease transmission 507 
dynamics at finer temporal scales to test the importance of heterogeneity in modes of RHDV 508 
transmissions and doses of infection on the mortality rates of rabbits susceptible to RHDV. 509 
Our analysis was restricted by practical limits to relatively long time intervals (ca. ten weeks) 510 
between capture sessions. This potentially affected our ability to capture important aspects of 511 
more rapid disease dynamics (e.g. short epidemics that last only a few days) in our CMR 512 
analysis. Furthermore, recapture rates of rabbits were low-to-moderate throughout the study 513 
period (mostly < 40%). Consequently, the accurate timing of sero-conversion of a large 514 
number of individuals in the Turretfield population remains unknown, perhaps affecting our 515 
population-level estimates of the force of infection or hazard ratios.  516 
 Further work is still needed to understand whether the time-delayed effect of MYXV 517 
reported in our study can be linked to interactions between the two co-circulating viruses. 518 
Therefore, in addition to more targeted analysis of CMR data, experiments should be used to 519 
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determine the strength and structure of possible interactions. Aspects to be studied include (i) 520 
whether infection by MYXV results in significant lower survival during subsequent RHDV 521 
infection and vice versa; and (ii) whether the timing of infection by one virus depletes the 522 
pool of susceptible rabbits for the other virus. These sorts of interactions could strongly affect 523 
the epidemiological dynamics of rabbits at the population level. 524 
 The analytical framework and results from this study lead to new questions regarding 525 
the importance of year-round epidemiological dynamics, modes of disease transmission and 526 
possible dose-response relationships in the wild. While these can only be solved with future 527 
empirical research, our study highlights that different factors may set limits on the efficacy of 528 
using RHDV and MYXV as biocontrol agents for invasive rabbits. If rabbits experience low 529 
dose exposure after epidemics, resulting in fewer fatalities, the population level effect of 530 
RHDV would be moderate, regardless of infection-induced mortality. This would have 531 
important ramifications for rabbit management, because modes of viral transmission needed 532 
to ensure high dose exposure would have to be given as much priority as engineering and 533 
releasing more virulent strains of RHDV for improved rabbit pest management. Nevertheless, 534 
if virulence remains relatively constant for RHDV and MYXV as we found, both viruses will 535 
continue to produce strong benefits as biocontrol agents, even if virulence is not as high as 536 
was observed shortly after the initial disease outbreaks. 537 
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 713 
Figure 1. Illustration of the state-space inference pathway for estimating the effects of 714 
disease on the survival of rabbits using capture-mark-recapture data (A – D). Disease state 715 
and size/age of individuals are known or inferred for each capture event: small/young rabbit 716 
with maternal antibodies, large/mature rabbit susceptible to disease, large/mature rabbit 717 
resistant to disease after surviving an infection. Unknown classes (grey vertical bars) of 718 
rabbits occur when rabbits are not captured: rabbits likely to be alive but disease state 719 
unknown, rabbit with unknown disease state likely to have died. Transition probabilities 720 
between different disease states arise from sequences of observed disease states (i.e. maternal 721 
antibodies  susceptible ΨMS, susceptible  susceptible ΨSS, susceptible  resistant ΨSR), 722 
allowing data-driven state-space estimation of unknown disease states for all individuals any 723 
time during their lifespans (ηit). This allows relative survival rates of rabbits in different 724 
disease states and age classes to be estimated. 725 
  726 
 727 
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 728 
Figure 2. Estimated average changes in monthly survival rates of rabbits in different disease 729 
states, namely 1) susceptible to rabbit haemorrhagic disease virus (RHDV) and immune to 730 
myxoma virus (MYXV) (red bars), 2) susceptible to MYXV and immune to RHDV (blue 731 
bars), 3) susceptible to both RHDV and MYXV (green bars), and 4) young rabbits < 90 days 732 
old of various disease states, including individuals with maternal antibodies against RHDV 733 
and/or MYXV (purple bars). Values represent odds ratios that compare survival rates to 734 
rabbits that survived previous infection of RHDV and MYXV (as indicated by seropositive 735 
antibody status for the respective virus for individuals > 90 days old). Black squares are 736 
posterior modes; vertical thick and thin bars are 50% and 95% credible intervals. Estimates 737 
are based on hyperpriors that ‘average’ the effects over the entire study period (2000-2016). 738 
 739 
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 740 
Figure 3. Estimated monthly rate at which susceptible rabbits (> 90 days old) become 741 
infected (force of infection) with rabbit haemorrhagic disease virus (RHDV) and myxoma 742 
virus (MYXV), respectively. Colours represent different seasons (light orange: autumn, dark 743 
violet: winter, light violet: spring, dark orange: summer). Black squares are posterior modes; 744 
vertical thick and thin bars are 50% and 95% credible intervals. Estimates are plotted on a 745 
continuous time scale, vertical broken lines indicate the 1st day of each year. 746 
